From trial efficacy to real-world effectiveness: evaluating the generalizability of cisplatin–gemcitabine–durvalumab in advanced biliary tract cancers
- DOI
- 10.1007/s00535-026-02535-w
- Published
- 2026-11-04
- Container
- Journal of Gastroenterology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00535-026-02535-w,
title = {From trial efficacy to real-world effectiveness: evaluating the generalizability of cisplatin–gemcitabine–durvalumab in advanced biliary tract cancers},
author = {Silvia Camera and Margherita Rimini and Masafumi Ikeda and Oluseyi Abidoye and Jessica Lucchetti and Lorenzo Antonuzzo and Jin Won Kim and Federico Nichetti and Anna Saborowski and Christoph Gerdes and Tiziana Pressiani and Caterina Vivaldi and Ilario Giovanni Rapposelli and Frederik Peeters and Chiara Braconi and David J. Pinato and Emiliano Tamburini and Chiara Pircher and Luisa Foltran and Stefano Tamberi and Florian Castet and Monica Verrico and Alessandro Parisi and Nuno Couto and Hong Jae Chon and Andrea Martirena and Angela Lamarca and Matteo Landriscina and Fabian Finkelmeier and Ester Oneda and Antonio Avallone and Emanuela Dell’Aquila and Lukas Perkhofer and Il Hwan Kim and Vincenzo Formica and Cidalia Maria de Sousa Pinto and Ingrid Garajova and Beodeul Kang and Salvatore Corallo and Elisabetta Fenocchio and Giovanni Farinea and Alessandro Pastorino and Anna Diana and Changhoon Yoo and Marta Schirripa and Maria Grazia Rodriquenz and Mario Scartozzi and Lucrezia Zumstein and Michele Ghidini and Gerald W. Prager and Giuseppe Aprile and Gian Paolo Spinelli and Su Yung-Yeh and Stephen L. Chan and Emily Warmington and Alessia Lancianese and Tomoyuki Satake and Tanios Bekaii-Saab and Guido Giordano and Daniele Lavacchi and Laura Passeri and Michele Ferrara and Federico Rossari and Federica Lo Prinzi and Minsu Kang and Alessandra Anna Prete and Silvia Bozzarelli and Mara Persano and Lorenzo Fornaro and Rita Balsano and Monica Niger and Sara Lonardi and Francesca Salani and Arndt Vogel and Gianluca Masi and Lorenza Rimassa and Andrea Casadei-Gardini},
year = {2026},
journal = {Journal of Gastroenterology},
doi = {10.1007/s00535-026-02535-w},
url = {https://doi.org/10.1007/s00535-026-02535-w}
}RIS
TY - JOUR TI - From trial efficacy to real-world effectiveness: evaluating the generalizability of cisplatin–gemcitabine–durvalumab in advanced biliary tract cancers AU - Silvia Camera AU - Margherita Rimini AU - Masafumi Ikeda AU - Oluseyi Abidoye AU - Jessica Lucchetti AU - Lorenzo Antonuzzo AU - Jin Won Kim AU - Federico Nichetti AU - Anna Saborowski AU - Christoph Gerdes AU - Tiziana Pressiani AU - Caterina Vivaldi AU - Ilario Giovanni Rapposelli AU - Frederik Peeters AU - Chiara Braconi AU - David J. Pinato AU - Emiliano Tamburini AU - Chiara Pircher AU - Luisa Foltran AU - Stefano Tamberi AU - Florian Castet AU - Monica Verrico AU - Alessandro Parisi AU - Nuno Couto AU - Hong Jae Chon AU - Andrea Martirena AU - Angela Lamarca AU - Matteo Landriscina AU - Fabian Finkelmeier AU - Ester Oneda AU - Antonio Avallone AU - Emanuela Dell’Aquila AU - Lukas Perkhofer AU - Il Hwan Kim AU - Vincenzo Formica AU - Cidalia Maria de Sousa Pinto AU - Ingrid Garajova AU - Beodeul Kang AU - Salvatore Corallo AU - Elisabetta Fenocchio AU - Giovanni Farinea AU - Alessandro Pastorino AU - Anna Diana AU - Changhoon Yoo AU - Marta Schirripa AU - Maria Grazia Rodriquenz AU - Mario Scartozzi AU - Lucrezia Zumstein AU - Michele Ghidini AU - Gerald W. Prager AU - Giuseppe Aprile AU - Gian Paolo Spinelli AU - Su Yung-Yeh AU - Stephen L. Chan AU - Emily Warmington AU - Alessia Lancianese AU - Tomoyuki Satake AU - Tanios Bekaii-Saab AU - Guido Giordano AU - Daniele Lavacchi AU - Laura Passeri AU - Michele Ferrara AU - Federico Rossari AU - Federica Lo Prinzi AU - Minsu Kang AU - Alessandra Anna Prete AU - Silvia Bozzarelli AU - Mara Persano AU - Lorenzo Fornaro AU - Rita Balsano AU - Monica Niger AU - Sara Lonardi AU - Francesca Salani AU - Arndt Vogel AU - Gianluca Masi AU - Lorenza Rimassa AU - Andrea Casadei-Gardini PY - 2026 JO - Journal of Gastroenterology DO - 10.1007/s00535-026-02535-w UR - https://doi.org/10.1007/s00535-026-02535-w ER -
APA
Camera, S., Rimini, M., Ikeda, M., Abidoye, O., Lucchetti, J., Antonuzzo, L., Kim, J. W., Nichetti, F., Saborowski, A., Gerdes, C., Pressiani, T., Vivaldi, C., Rapposelli, I. G., Peeters, F., Braconi, C., Pinato, D. J., Tamburini, E., Pircher, C., Foltran, L., Tamberi, S., Castet, F., Verrico, M., Parisi, A., Couto, N., Chon, H. J., Martirena, A., Lamarca, A., Landriscina, M., Finkelmeier, F., Oneda, E., Avallone, A., Dell’Aquila, E., Perkhofer, L., Kim, I. H., Formica, V., Pinto, C. M. D. S., Garajova, I., Kang, B., Corallo, S., Fenocchio, E., Farinea, G., Pastorino, A., Diana, A., Yoo, C., Schirripa, M., Rodriquenz, M. G., Scartozzi, M., Zumstein, L., Ghidini, M., Prager, G. W., Aprile, G., Spinelli, G. P., Yung-Yeh, S., Chan, S. L., Warmington, E., Lancianese, A., Satake, T., Bekaii-Saab, T., Giordano, G., Lavacchi, D., Passeri, L., Ferrara, M., Rossari, F., Prinzi, F. L., Kang, M., Prete, A. A., Bozzarelli, S., Persano, M., Fornaro, L., Balsano, R., Niger, M., Lonardi, S., Salani, F., Vogel, A., Masi, G., Rimassa, L., & Casadei-Gardini, A. (2026). From trial efficacy to real-world effectiveness: evaluating the generalizability of cisplatin–gemcitabine–durvalumab in advanced biliary tract cancers. Journal of Gastroenterology. https://doi.org/10.1007/s00535-026-02535-w
Source records
- crossref · retrieved 2026-11-07T07:44:56.693Z